1. Berger MS, Prados DP (2005) Neuro-Oncology. Elsevier Saunders, Philadelphia
2. Filippini G (2002) Epidemiologia descrittiva, possibili fattori causali. In: Sghirlanzoni A, Boiardi A (ed) La terapia dei tumori cerebrali maligni dell’adulto e del bambino. Springer, Italia
3. Braunwald E, Fauci AS, Kasper DL et al (2002) Principi di Medicina Interna. Mc Grow-Hill
4. Gururangan S, Cokgor L, Rich JN et al (2001) Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol 3:246–250
5. Rich N, Affronti ML, Day JM et al (2007) Overall survival of primary glioblastoma (GBM) patients (pts) receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent chemotherapy. J Clin Oncology, ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S [June 20 Suppl]:2070